Sheffield Medical Technologies Inc. deal

SHM entered into an option and sponsored research agreement with Children's Hospital (Boston) to develop clotrimazole and its metabolites to treat sickle cell anemia. The option includes exclusive rights to an issued U.S. patent covering clotrimazole in the treatment of the disorder, and rights to data from preclinical and pilot clinical studies. ...